PerkinElmer Stock Soars While Molecular Devices Falls

After announcing its third-quarter results last week, PerkinElmer watched its stock jump 17 percent while Molecular Devices fell 13 percent for the five-day period ending Tuesday as the BioCommerce Week Index ended three consecutive weeks of losses.

Twelve of the 15 companies closed the week with their stock prices up over last week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.